TMO Thermo Fisher Scientific Inc

Price (delayed)

$539.93

Market cap

$211.54B

P/E Ratio

28.49

Dividend/share

$1.16

EPS

$18.95

Enterprise value

$239.91B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
The company's equity rose by 15% YoY and by 3.3% QoQ
Thermo Fisher Scientific's revenue has increased by 12% YoY and by 4.1% from the previous quarter
The debt has soared by 61% YoY but it has decreased by 9% QoQ
Thermo Fisher Scientific's quick ratio has plunged by 51% YoY
TMO's EPS is down by 13% year-on-year and by 2.1% since the previous quarter

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
391.79M
Market cap
$211.54B
Enterprise value
$239.91B
Valuations
Price to earnings (P/E)
28.49
Price to book (P/B)
5
Price to sales (P/S)
4.94
EV/EBIT
26.7
EV/EBITDA
20.01
EV/Sales
5.6
Earnings
Revenue
$42.82B
EBIT
$8.99B
EBITDA
$11.99B
Free cash flow
$6.37B
Per share
EPS
$18.95
Free cash flow per share
$16.24
Book value per share
$108.04
Revenue per share
$109.23
TBVPS
$78.92
Balance sheet
Total assets
$90.58B
Total liabilities
$48.23B
Debt
$30.26B
Equity
$42.29B
Working capital
$7.1B
Liquidity
Debt to equity
0.72
Current ratio
1.65
Quick ratio
0.88
Net debt/EBITDA
2.37
Margins
EBITDA margin
28%
Gross margin
46.6%
Net margin
17.4%
Operating margin
22.5%
Efficiency
Return on assets
8.5%
Return on equity
18.3%
Return on invested capital
19.4%
Return on capital employed
11.3%
Return on sales
21%
Dividend
Dividend yield
0.21%
DPS
$1.16
Payout ratio
6.1%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
3.25%
1 week
6.15%
1 month
-0.67%
1 year
-5.11%
YTD
-19.08%
QTD
6.46%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$42.82B
Gross profit
$19.97B
Operating income
$9.64B
Net income
$7.44B
Gross margin
46.6%
Net margin
17.4%
The net margin has decreased by 23% YoY and by 6% QoQ
Thermo Fisher Scientific's operating margin has decreased by 20% YoY and by 5% from the previous quarter
Thermo Fisher Scientific's net income has decreased by 13% YoY and by 2.2% from the previous quarter
Thermo Fisher Scientific's revenue has increased by 12% YoY and by 4.1% from the previous quarter

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
P/E
28.49
P/B
5
P/S
4.94
EV/EBIT
26.7
EV/EBITDA
20.01
EV/Sales
5.6
TMO's EPS is down by 13% year-on-year and by 2.1% since the previous quarter
The stock's price to earnings (P/E) is 11% less than its 5-year quarterly average of 31.9 and 5% less than its last 4 quarters average of 30.0
The company's equity rose by 15% YoY and by 3.3% QoQ
The P/B is 14% below the last 4 quarters average of 5.8 but 11% above the 5-year quarterly average of 4.5
The P/S is 15% below the last 4 quarters average of 5.8
Thermo Fisher Scientific's revenue has increased by 12% YoY and by 4.1% from the previous quarter

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's return on invested capital is down by 40% year-on-year and by 10% since the previous quarter
TMO's ROA is down by 34% YoY and by 8% from the previous quarter
The ROE has contracted by 27% YoY and by 5% from the previous quarter
TMO's ROS is down by 23% year-on-year and by 5% since the previous quarter

Dividends

What is TMO's dividend history
DPS
$1.16
Dividend yield
0.21%
Payout ratio
6.1%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 88% greater than the total liabilities
Thermo Fisher Scientific's total liabilities has soared by 56% YoY but it has decreased by 7% from the previous quarter
Thermo Fisher Scientific's quick ratio has plunged by 51% YoY
The debt is 28% lower than the equity
The debt has soared by 61% YoY but it has decreased by 9% QoQ
Thermo Fisher Scientific's debt to equity has increased by 41% YoY but it has decreased by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.